期刊文献+
共找到52篇文章
< 1 2 3 >
每页显示 20 50 100
Monoamine Oxidase-B Inhibitor Rasagiline Effects on Motor and Non-Motor Symptoms in Individuals with Parkinson’s Disease: A Systematic Review and Meta-Analysis
1
作者 Paula Abola Mitchell Wolden 《Advances in Parkinson's Disease》 CAS 2024年第3期27-56,共30页
Objective: In the manuscript titled Monoamine Oxidase-B Inhibitor Rasagiline Effects on Motor and Non-Motor Symptoms in Individuals with Parkinsons Disease: A Systematic Review and Meta-Analysis, the objective was to ... Objective: In the manuscript titled Monoamine Oxidase-B Inhibitor Rasagiline Effects on Motor and Non-Motor Symptoms in Individuals with Parkinsons Disease: A Systematic Review and Meta-Analysis, the objective was to conduct a systematic review with meta-analysis to investigate the effects that Rasagiline has on motor and non-motor symptoms in individuals with PD. Introduction: Rasagiline is a second-generation monoamine oxidase-B (MAO-B) inhibitor used both as monotherapy and adjunctive therapy for Parkinsons Disease (PD). Methods: A systematic literature search and meta-analysis were performed with randomized control trials that investigated the effects of Rasagiline on motor and non-motor symptoms in individuals with PD. The systematic search was conducted in PubMed, Cochrane, and EBSCO databases. Methodological quality was assessed using the Cochrane Grading Recommendations Assessment, Development and Evaluation approach. Results: Fourteen studies were included in our review. There were trivial to small and statistically significant improvements in motor symptoms for individuals with PD treated with Rasagiline compared to placebo. Non-motor symptoms showed no significant improvement with Rasagiline compared to placebo in five of six meta-analyses. Results were based on very low to moderate certainty of evidence. Conclusion: 1 mg/day Rasagiline significantly improved Parkinsonian motor symptoms in individuals with PD compared with placebo. For all outcomes, the 1 mg/day Rasagiline group was favored over the placebo group. 展开更多
关键词 Parkinson’s Disease Monoamine Oxidase-B Inhibitor RASAGILINE non-motor symptoms Motor symptoms UPDRS PDQ-39 OFF Time
下载PDF
Effects of a Cocktail Supplement of Ginkgo Biloba and Acai Extract on Cognitive Symptoms of Parkinson’s Disease
2
作者 Yulia Dubrovensky 《Advances in Parkinson's Disease》 CAS 2024年第3期57-72,共16页
Parkinson’s Disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, including cognitive impairment. Current treatments often involve synthetic drugs with significant side effects a... Parkinson’s Disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, including cognitive impairment. Current treatments often involve synthetic drugs with significant side effects and potential for dependency. This study investigates the effects of a natural supplement combination of Ginkgo Biloba and Acai Extract on cognitive symptoms in a 77-year-old male with PD. The participant underwent a three-month supplementation regimen, with cognitive function assessed using the Montreal Cognitive Assessment (MoCA) test before and after the intervention. The results indicated an improvement in cognitive scores, suggesting that the combination of Ginkgo Biloba and Acai Extract may offer a promising alternative or adjunct to conventional PD treatments. This study highlights the potential of natural supplements in managing PD symptoms and calls for further research with larger sample sizes to confirm these findings. Human data was performed in accordance with the Declaration of Helsinki by the Roxbury District IRB Board (IRB Number: IRB00011767). 展开更多
关键词 Parkinson’s Disease (PD) Cognitive Function Ginkgo Biloba Acai Extract Neurodegenerative Disorders Natural Supplements Cognitive symptoms Montreal Cognitive Assessment (MoCA) Dopaminergic Neurons Antioxidants Neuroprotection non-motor symptoms Oxidative Stress POLYPHENOLS
下载PDF
Congenital stapes suprastructure fixation presenting with fluctuating auditory symptoms:A case report
3
作者 Sun Choi Seok Hyun Park +1 位作者 Ji Su Kim Jiwon Chang 《World Journal of Clinical Cases》 SCIE 2023年第1期249-254,共6页
BACKGROUND Stapes ankylosis is a rare cause of conductive hearing loss,and stapes suprastructure fixation is extremely rare with fewer than 30 reported cases.Patients usually visit the clinic with non-progressive cond... BACKGROUND Stapes ankylosis is a rare cause of conductive hearing loss,and stapes suprastructure fixation is extremely rare with fewer than 30 reported cases.Patients usually visit the clinic with non-progressive conductive hearing loss that typically began in the early years of life.CASE SUMMARY Herein,we report a case of a 37-year-old female with an isolated stapedial suprastructure fixation.The patient presented with unusual fluctuating auditory symptoms of tinnitus,ear fullness and mixed hearing loss.Pre-operative temporal bone computed tomography findings and operative findings revealed an isolated stapedial suprastructure fixation with monopod stapes caused by elongated pyramidal eminence.The hearing threshold recovered completely,and fluctuating auditory symptoms disappeared after the surgery.CONCLUSION This is the first report of stapedial suprastructure fixation with fluctuating auditory symptoms.Successful results are expected with surgical treatment. 展开更多
关键词 Isolated stapes ankylosis Stapes suprastructure fixation Elongated pyramidal eminence Stapes monopod fluctuating auditory symptoms Exploratory tympanotomy Case report
下载PDF
Non-motor signs and symptoms in Parkinson’s disease
4
作者 Kazuo Abe 《Health》 2012年第11期1133-1137,共5页
Motor symptoms are cardinal clinical features of Parkinson’s disease (PD). Progress in drug therapy and rehabilitation has been presenting beneficial effect for motor symptoms. However, non-motor symptoms and signs i... Motor symptoms are cardinal clinical features of Parkinson’s disease (PD). Progress in drug therapy and rehabilitation has been presenting beneficial effect for motor symptoms. However, non-motor symptoms and signs in PD have been accumulated growing attentions and its amelioration may also give beneficial effect for PD patients’ and their care givers’ quality of life. In this mini-review, I overviewed non-motor symptoms and signs in PD. 展开更多
关键词 Parkinson’s Disease (PD) non-motor SIGNS and symptoms Activities of Daily Livings (ADL) Quality of Life (QOL)
下载PDF
Non-Motor Symptoms in Parkinson’s Disease Patients—An Observational Study
5
作者 Thomas Gabriel Schreiner 《Journal of Biosciences and Medicines》 2020年第6期1-16,共16页
<strong>Background: </strong>Parkinson’s disease (PD) remains a challenge for neurologists, particularly in its advanced stages when non-motor symptoms become a burden for the patient. While motor symptom... <strong>Background: </strong>Parkinson’s disease (PD) remains a challenge for neurologists, particularly in its advanced stages when non-motor symptoms become a burden for the patient. While motor symptoms may be satisfactorily controlled with levodopa therapy or continuous levodopa/carbidopa intestinal gel (LCIG) administration, autonomic, sleep and mental disorders are hard to treat. During the last years, researchers have shifted their interest more to non-motor symptoms, PD being now considered a complex multiorgan impairment. <strong>Objective:</strong> The aim of this study was to describe non-motor symptoms in 40 Romanian patients diagnosed with PD, under conventional and LCIG administration treatment. <strong>Methods: </strong>A cross-sectional observational study was conducted, consisting of two groups of 20 patients each: the first group comprised PD patients who received conventional Levodopa treatment, while the second group was formed of patients receiving LCIG therapy. Various data concerning patient’s age, gender, duration of illness, comorbidities, motor and non-motor symptoms were recorded. The data were processed in SPSS v.20. <strong>Results: </strong>Subjects under continuous LCIG administration, although showing amelioration of motor symptoms, complained more frequently of constipation, mental, and sleeping disorders (statistically significant). Regarding anosmia, orthostatic hypotension, hypersalivation, urinary incontinence and restless legs syndrome, no statistical significant difference was observed between the two groups (p > 0.05). <strong>Conclusion:</strong> Nowadays, more research is conducted on non-motor symptoms in PD patients, as therapeutic measures try to limit these burdens, in order to improve patient’s quality of life. 展开更多
关键词 Parkinson’s Disease non-motor symptoms Conventional Treatment Levodopa/Carbidopa Intestinal Gel
下载PDF
Genetic factors associated with non-motor symptoms in Parkinson’s disease
6
作者 Yilun Ge Kai Li Chunfeng Liu 《Journal of Translational Neuroscience》 2019年第1期15-29,共15页
Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease. It is a complex syndrome with heterogeneous aetiologies, pathogenesis and manifestations. Patients with PD may... Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease. It is a complex syndrome with heterogeneous aetiologies, pathogenesis and manifestations. Patients with PD may present with motor symptoms and various non-motor symptoms (NMSs). NMSs have been reported in almost every diagnosed case of PD and usually precede motor symptoms. Multiple factors have been proved to be associated with the occurrence of NMSs in PD, among which genetic differentiation is a featured one. With the development of sequencing techniques, an increasing number of NMS-related genetic factors have been identified. This article reviews some of the latest discoveries in this regard. 展开更多
关键词 Parkinson's disease (PD) non-motor symptoms (NMSs) GENETIC DIFFERENTIATION
下载PDF
慢性精神分裂症患者症状波动与患者外周血细胞计数水平相关性研究 被引量:1
7
作者 朱烨青 苏志斌 官廖昊 《中国医药指南》 2024年第3期1-4,共4页
目的 探讨慢性精神分裂症患者外周血细胞计数水平及其与临床症状波动之间的相关性。方法 纳入2022年1月于我院精神科长期住院的慢性精神分裂症患者200例。进行半年的动态随访观察,所有受试者入组后进行一次阳性与阴性症状量表(PANSS)评... 目的 探讨慢性精神分裂症患者外周血细胞计数水平及其与临床症状波动之间的相关性。方法 纳入2022年1月于我院精神科长期住院的慢性精神分裂症患者200例。进行半年的动态随访观察,所有受试者入组后进行一次阳性与阴性症状量表(PANSS)评估临床症状及一次血常规检测后进入观察期,观察期间每2周进行一次PANSS评估、每4周进行一次血常规检测,期间若病情波动则被划分为病情波动组并终止观察、半年未波动则为未波动组,比较两组PANSS及血常规指标。结果 通过观察得到病情波动组人数为86例,病情未波动组为114例;病情波动组阳性症状及兴奋评分均高于病情未波动组;病情波动组MON、WBC、NEU、LYM均高于病情未波动组,NLR、SIII均高于病情未波动组,PLT、PLR均低于病情未波动组,以上差异均无统计学意义(P> 0.05);通过比较同一患者波动期NLR、PLR、MLR值均高于同一患者稳定期。此外,波动期患者白细胞计数(WBC)、中性粒细胞(NEU)、血小板(PLT)、单核细胞计数(MON)均高于稳定期。在淋巴细胞计数方面,波动期和稳定期无显著差异。病情波动组阳性症状及兴奋评分与PLR、SIII呈正相关(P <0.05)。结论 慢性精神分裂症患者阳性症状、兴奋症状波动存在炎症紊乱,WBC、NEU、SIII可作为慢性精神分裂症症状波动预测因子。 展开更多
关键词 慢性精神分裂症 血细胞计数 炎性指标 症状波动
下载PDF
2型糖尿病周围神经病变症状与血糖波动的相关性研究
8
作者 何春玲 吴涵 +2 位作者 程锦瀚 赵咏莉 姚新明 《皖南医学院学报》 CAS 2024年第3期245-248,共4页
目的:研究2型糖尿病周围神经病变(DPN)症状与血糖波动的相关性。方法:选取112例2型DPN患者作为研究对象,根据是否存在周围神经病变临床症状分为无症状组(DPN1组)和有症状组(DPN2组),收集性别、年龄、病程、生化指标、血糖波动指标,比较... 目的:研究2型糖尿病周围神经病变(DPN)症状与血糖波动的相关性。方法:选取112例2型DPN患者作为研究对象,根据是否存在周围神经病变临床症状分为无症状组(DPN1组)和有症状组(DPN2组),收集性别、年龄、病程、生化指标、血糖波动指标,比较两组各指标的差异,并通过多因素Logistic回归分析DPN症状与血糖波动指标的关系。结果:DPN2组TG水平低于DPN1组、Cys-C水平高于DPN1组(P<0.05),DPN2组CV、SDBG、MAGE、TAR、TBR、MBG水平均高于DPN1组,TIR水平低于DPN1组(P<0.05)。多因素Logistic回归分析显示,Cys-C、CV升高是DPN独立危险因素(P<0.05),而TIR下降是DPN的保护性因素(P<0.05)。结论:HbA1c等同情况下,血糖波动和Cys-C升高是DPN症状的危险因素。 展开更多
关键词 2型糖尿病 周围神经病变 症状 糖化血红蛋白 血糖波动
下载PDF
急性脑梗死溶栓患者术后临床症状反复发作的相关因素分析
9
作者 潘恬 杨立 +1 位作者 张慧理 孙海芬 《中外医学研究》 2024年第1期152-155,共4页
目的:探讨急性脑梗死(acute cerebral infarction,ACI)溶栓患者术后临床症状反复发作的相关影响因素。方法:采用回顾性调查方法对2019年1月—2023年2月在张家港市第二人民医院神经内科诊治的90例ACI溶栓患者资料进行分析,以术后出现偏... 目的:探讨急性脑梗死(acute cerebral infarction,ACI)溶栓患者术后临床症状反复发作的相关影响因素。方法:采用回顾性调查方法对2019年1月—2023年2月在张家港市第二人民医院神经内科诊治的90例ACI溶栓患者资料进行分析,以术后出现偏瘫、失语等临床症状反复发作的56例(62.22%)为观察组,未出现临床症状反复发作的34例(37.78%)为对照组,并对其进行单因素分析、logistic回归分析及受试者工作特征(receiver operating characteristic,ROC)曲线分析,研究ACI溶栓患者术后临床症状反复发作的相关因素。结果:单因素分析分析结果显示,两组性别、年龄、吸烟史、高血压史、糖尿病史、发病时间、血清生化指标比较,差异无统计学意义(P>0.05);两组美国国立卫生研究院卒中量表(National Institute of Health stroke scale,NIHSS)评分、心房颤动、梗死部位水平比较,差异有统计学意义(P<0.05)。logistic回归分析结果显示,NIHSS评分、心房颤动及梗死部位为ACI溶栓患者术后临床症状反复发作的独立危险因素(P<0.05)。ROC曲线分析结果显示,NIHSS评分、心房颤动及梗死部位的ROC曲线下面积(area under curve,AUC)分别为0.899、0.637、0.654,敏感度较高。结论:ACI溶栓患者术后临床症状反复发作与脑卒中神经缺损程度、心房颤动及梗死部位有关。 展开更多
关键词 急性脑梗死 溶栓 临床症状反复发作 影响因素
下载PDF
Sex modulates the outcome of subthalamic nucleus deep brain stimulation in patients with Parkinson's disease 被引量:3
10
作者 Tian-Shuo Yuan Ying-Chuan Chen +5 位作者 De-Feng Liu Ruo-Yu Ma Xin Zhang Ting-Ting Du Guan-Yu Zhu Jian-Guo Zhang 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第4期901-907,共7页
There are many documented sex differences in the clinical course,symptom expression profile,and treatment response of Parkinson’s disease,creating additional challenges for patient management.Although subthalamic nuc... There are many documented sex differences in the clinical course,symptom expression profile,and treatment response of Parkinson’s disease,creating additional challenges for patient management.Although subthalamic nucleus deep brain stimulation is an established therapy for Parkinson’s disease,the effects of sex on treatment outcome are still unclear.The aim of this retrospective observational study,was to examine sex differences in motor symptoms,nonmotor symptoms,and quality of life after subthalamic nucleus deep brain stimulation.Outcome measures were evaluated at 1 and 12 months post-operation in 90 patients with Parkinson’s disease undergoing subthalamic nucleus deep brain stimulation aged 63.00±8.01 years(55 men and 35 women).Outcomes of clinical evaluations were compared between sexes via a Student’s t-test and within sex via a paired-sample t-test,and generalized linear models were established to identify factors associated with treatment efficacy and intensity for each sex.We found that subthalamic nucleus deep brain stimulation could improve motor symptoms in men but not women in the on-medication condition at 1 and 12 months post-operation.Restless legs syndrome was alleviated to a greater extent in men than in women.Women demonstrated poorer quality of life at baseline and achieved less improvement of quality of life than men after subthalamic nucleus deep brain stimulation.Furthermore,Hoehn-Yahr stage was positively correlated with the treatment response in men,while levodopa equivalent dose at 12 months post-operation was negatively correlated with motor improvement in women.In conclusion,women received less benefit from subthalamic nucleus deep brain stimulation than men in terms of motor symptoms,non-motor symptoms,and quality of life.We found sex-specific factors,i.e.,Hoehn-Yahr stage and levodopa equivalent dose,that were related to motor improvements.These findings may help to guide subthalamic nucleus deep brain stimulation patient selection,prognosis,and stimulation programming for optimal therapeutic efficacy in Parkinson’s disease. 展开更多
关键词 chronic effect deep brain stimulation generalized linear model initial effect motor symptoms non-motor symptoms Parkinson’s disease quality of life SEX subthalamic nucleus
下载PDF
Study of an integrated non-motor symptoms questionnaire for Parkinson's disease 被引量:7
11
作者 YU Bo XIAO Zhi-ying +2 位作者 LI Jia-zhen YUAN Jing LIU Yi-ming 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第11期1436-1440,共5页
Background Although the validity of non-motor symptoms screening questionnaire (NMSQuest) for Parkinson's disease has been verified in several recent researches, the specificity of the questionnaire is still in dou... Background Although the validity of non-motor symptoms screening questionnaire (NMSQuest) for Parkinson's disease has been verified in several recent researches, the specificity of the questionnaire is still in doubt. This study aimed to compare the non-motor symptoms (NMS) in Parkinson's disease (PD) with a medically ill control group. Methods In this study, the first comprehensive clinic-based NMS screening questionnaire for PD developed by the Parkinson's Disease Non-Motor Group (PDNMG) was used. Data from 90 PD patients and 270 sex-and age-matched control subjects, including stroke (n=90), heart disease (n=-90) and diabetes (n=-90) were analyzed. Results Compared with control group, NMS was more common in PD; on an average, most PD patients reported more than 12 non-motor items. There was a correlation of total NMS score in PD patients with Hoehn & Yahr Staging, but not with age, sex distribution, disease duration, or age at disease onset. Additionally, depression, constipation and impaired olfaction which occurred prior to the motor symptoms of PD were reported in this study. Conclusions NMS are more common in PD patients. There are some NMS that occurred at the preclinical stage of PD and might predict the onset of motor symptoms of PD patients. 展开更多
关键词 Parkinson's disease non-motor symptoms QUESTIONNAIRE
原文传递
静脉溶栓治疗的急性脑梗死患者早期症状反复波动的相关因素分析 被引量:14
12
作者 王飞 高丽 +1 位作者 沈沸 李焰生 《临床神经病学杂志》 CAS 2019年第5期356-358,共3页
目的探讨静脉溶栓的急性脑梗死患者溶栓24 h内症状反复波动的相关因素。方法收集在发病4.5 h内接受重组组织型纤溶酶原激活剂(rt-PA)静脉溶栓的急性脑梗死患者101例,分为波动组与无波动组。收集两组患者的临床资料,并进行比较。结果波... 目的探讨静脉溶栓的急性脑梗死患者溶栓24 h内症状反复波动的相关因素。方法收集在发病4.5 h内接受重组组织型纤溶酶原激活剂(rt-PA)静脉溶栓的急性脑梗死患者101例,分为波动组与无波动组。收集两组患者的临床资料,并进行比较。结果波动组与无波动组患者的年龄、性别、溶栓前血压、溶栓前INR、发病-溶栓时间、低密度脂蛋白胆固醇(LDL-C)水平及高血压病、糖尿病史/糖化血红蛋白(HbA1c)>6%、吸烟史、TOAST分型、溶栓后24 h内颅内出血的比率差异均无统计学意义(均P>0.05)。波动组溶栓前NIHSS>3分及前循环梗死的比率显著高于无波动组(均P<0.05)。多因素Logistic回归分析显示,NIHSS>3分(OR=2.953,95%CI:1.044~8.354,P=0.041)和梗死部位(OR=4.020,95%CI:1.067~15.140,P=0.040)是症状波动的独立相关因素。结论静脉溶栓24 h内的症状反复波动与卒中严重程度及梗死部位相关。 展开更多
关键词 静脉溶栓 脑梗死 症状波动 相关因素
下载PDF
帕金森病患者非运动症状波动的临床特点 被引量:11
13
作者 梁波 黄磊 +2 位作者 李雪莲 王尚培 陈先文 《临床神经病学杂志》 CAS 北大核心 2015年第3期188-191,共4页
目的探讨帕金森病(PD)患者非运动症状波动的临床特点。方法采用剂末现象问卷(WOQ-19)评价121例原发性PD患者的运动症状波动和非运动症状波动,并采用视觉模拟评分法(VAS)对WOQ-19的每一项症状进行量化。采集患者的一般信息及服药情况,同... 目的探讨帕金森病(PD)患者非运动症状波动的临床特点。方法采用剂末现象问卷(WOQ-19)评价121例原发性PD患者的运动症状波动和非运动症状波动,并采用视觉模拟评分法(VAS)对WOQ-19的每一项症状进行量化。采集患者的一般信息及服药情况,同时采用统一PD评定量表Ⅲ(UPDRSⅢ)和Hoehn-Yahr量表(H-Y分级)评价患者运动功能及对进行病程分级。结果 121例PD患者中,114例(94.2%)有非运动症状,其中44例(38.6%)有非运动症状波动。非运动症状中,焦虑、情绪低落/思维迟钝、情绪变化的发生率较高。在非运动症状波动中,焦虑、情绪变化、多汗、情绪低落/思维迟钝的症状波动发生率较高。神经精神性症状波动发生率(42.3%)显著高于自主神经性症状(27.9%)与感觉性症状(23.4%)(均P<0.05)。患者焦虑、情绪变化、情绪低落/思维迟钝、多汗、疼痛、酸痛、麻木、腹部不适感的VAS评分在服药后明显降低(均P<0.05)。非运动症状波动患者病程、服药年限、H-Y分级、UPDRSⅢ开期及关期评分、复方左旋多巴剂量及左旋多巴等效剂量均显著高于无波动患者(均P<0.05)。兼有运动症状、非运动症状波动患者UPDRSⅢ关期评分及左旋多巴等效剂量均明显高于单纯运动症状波动患者(均P<0.05)。结论 PD患者非运动症状波动发生率约40%,神经精神性非运动症状波动更频繁。非运动症状波动与病程及服药年限长,H-Y分级、UPDRSⅢ评分及左旋多巴等效剂量高,同时兼有运动症状波动等因素有关。 展开更多
关键词 帕金森病 非运动症状 波动 临床特点
下载PDF
急性缺血性卒中围静脉溶栓时间窗临床症状波动的静脉溶栓研究 被引量:7
14
作者 陈忠伦 张杉杉 +4 位作者 张献文 李肇坤 浦明军 都泓材 段劲峰 《中国卒中杂志》 2020年第9期1010-1014,共5页
目的探讨急性缺血性卒中患者围静脉溶栓时间窗临床症状波动的患者进行静脉溶栓治疗的临床特征及预后分析。方法前瞻性纳入绵阳市中心医院2013年10月-2018年6月连续登记的发病4.5 h内进行静脉溶栓的患者,以实施静脉溶栓时NIHSS评分较入院... 目的探讨急性缺血性卒中患者围静脉溶栓时间窗临床症状波动的患者进行静脉溶栓治疗的临床特征及预后分析。方法前瞻性纳入绵阳市中心医院2013年10月-2018年6月连续登记的发病4.5 h内进行静脉溶栓的患者,以实施静脉溶栓时NIHSS评分较入院时NIHSS评分上下波动2分作为临床症状波动判断标准,将所有纳入患者分为无变化组、波动组。分析比较两组患者的临床特征及24 h出血转化率、出院NIHSS评分、3个月预后良好(mRS评分≤2分)和全因死亡率,多因素Logistic回归分析围静脉溶栓时间窗发生临床症状波动的影响因素。结果共纳入156例,其中男性110例(70.5%),年龄范围42~87岁,平均65±13岁,发生围静脉溶栓时间窗临床症状波动41例(26.3%)。与无变化组患者相比,波动组患者年龄、基线NIHSS评分、糖尿病比例、高血压比例、随机血糖水平、后循环梗死比例较高,差异均具有统计学意义。两组患者的24 h出血转化率、出院NI HSS评分、3个月良好预后率、3个月时全因死亡率差异无统计学意义。Logistic回归分析发现年龄(每增加10岁:OR 1.143,95%CI 1.016~1.836,P=0.040)、基线NIHSS评分(每增加1分:OR 1.353,95%CI 1.053~1.393,P=0.006)、随机血糖(每增加1 mmol/L:OR 2.120,95%CI 1.185~2.748,P=0.001)、后循环梗死(OR 2.603,95%CI 1.037~3.950,P=0.042)是围静脉溶栓时间窗临床症状波动的独立危险因素。结论尽管高龄、NIHSS评分高、血糖水平高、后循环梗死患者容易出现围静脉溶栓时间窗临床症状波动,但对终点事件并无影响。对于出现临床症状波动的患者,溶栓可使患者获益。 展开更多
关键词 卒中 静脉溶栓 时间窗 临床症状波动
下载PDF
中晚期帕金森病症状波动的治疗进展 被引量:3
15
作者 卫红涛 朱珠 《实用药物与临床》 CAS 2020年第2期97-102,共6页
帕金森病(Parkinson′s disease PD)作为神经系统常见退行性疾病在中晚期患者中常会出现症状波动和进行性加重包括“剂末现象”、“开关现象”、“异动症”、“晨僵”等近年来随着对PD研究的进展多种新药、新复方药与新剂型进入临床研... 帕金森病(Parkinson′s disease PD)作为神经系统常见退行性疾病在中晚期患者中常会出现症状波动和进行性加重包括“剂末现象”、“开关现象”、“异动症”、“晨僵”等近年来随着对PD研究的进展多种新药、新复方药与新剂型进入临床研究与上市销售这些药物或剂型有助于改善中晚期的症状波动包括吸入性多巴胺补充剂透皮吸收的多巴胺受体激动剂贴剂以及一些已上市药物通过更改剂型应用缓控释技术改善药物的吸收速率以达到延长作用时间从而持续改善帕金森病症状的目的此外对中晚期PD的治疗还可以通过脑深部电刺激术(DBS)来改善症状波动针对PD及患者的共病治疗精细而又复杂需要进行全程管理药师在这一方面可以发挥作用本文概述了近年来PD症状波动的治疗进展. 展开更多
关键词 帕金森病 症状波动 异动症 脑深部电刺激术 临床药师
下载PDF
心理护理干预对骨科全身麻醉患者心理波动的影响研究 被引量:6
16
作者 李春晖 王洋 张彦玲 《中国继续医学教育》 2019年第2期184-186,共3页
目的探讨心理护理干预在骨科患者全身麻醉中的护理效果及对心理波动的影响。方法选择2014年5月—2018年3月骨科患者120例作为对象,根据护理方法分为对照组和观察组,从强迫、抑郁、敌对、焦虑角度进行心理评估,比较两组护理效果及对心理... 目的探讨心理护理干预在骨科患者全身麻醉中的护理效果及对心理波动的影响。方法选择2014年5月—2018年3月骨科患者120例作为对象,根据护理方法分为对照组和观察组,从强迫、抑郁、敌对、焦虑角度进行心理评估,比较两组护理效果及对心理波动的影响。结果观察组护理后3 d强迫评分(0.84±0.13)分、抑郁(0.82±0.11)分、敌对(0.94±0.13)分、焦虑(0.78±0.11)分,均低于对照组的强迫评分(1.59±0.32)分、抑郁(1.94±0.35)分、敌对(1.88±0.34)分、焦虑(1.74±0.32)分,差异有统计学意义(P <0.05)。结论心理护理干预用于骨科患者全麻中效果理想,能减轻患者心理波动。 展开更多
关键词 心理护理干预 症状自评量表 骨科患者 全身麻醉 护理效果 心理波动
下载PDF
老年男性,波动性肌无力并口干、眼干3个月——重症肌无力Lambert-Eaton叠加综合征
17
作者 陈艺聪 曾慧鈃 +2 位作者 刘刚 曾进胜 余剑 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2022年第8期508-512,共5页
本文报告1例重症肌无力Lambert-Eaton叠加综合征。患者男,64岁,波动性四肢近端无力、吞咽费力和活动后呼吸困难3个月,呈晨轻暮重和病态疲劳,伴口干和眼干的自主神经受损表现,神经系统查体示四肢近端肌力约4级,四肢腱反射减退,新斯的明... 本文报告1例重症肌无力Lambert-Eaton叠加综合征。患者男,64岁,波动性四肢近端无力、吞咽费力和活动后呼吸困难3个月,呈晨轻暮重和病态疲劳,伴口干和眼干的自主神经受损表现,神经系统查体示四肢近端肌力约4级,四肢腱反射减退,新斯的明试验阳性,电生理显示多条神经静止时运动传导波幅减低(左正中、面和尺神经均≤5.0 mV),大力收缩15 s后波幅上升超过2倍,左面神经、双尺神经重复电刺激(repetitive nerve stimulation,RNS)低频(3 Hz、5 Hz)递减(17.4%~35.6%)、高频(15 Hz、20 Hz)递增(153%~328%),血清AChR-Ab和Titin-Ab阳性,VGCC-Ab阴性,合并胸腺瘤,最终诊断为重症肌无力Lambert-Eaton叠加综合征(myasthenia gravis Lambert-Eaton overlap syndrome,MLOS)。经小剂量糖皮质激素(甲泼尼龙8~24 mg/d)抑制免疫联合胆碱酯酶抑制剂(溴比斯的明60 mg,2~4次/d)控制症状,病情好转后行胸腺瘤切除,肌无力症状明显改善、眼干消失。MLOS临床罕见,以波动性肌无力为主要表现时,容易忽略自主神经受累表现和遗漏检查,影响准确而全面的诊断。通过报告1例MLOS病例,以提高对MLOS诊断和治疗要点的认识。 展开更多
关键词 波动性肌无力 自主神经受损 重症肌无力 LAMBERT-EATON肌无力综合征 Lambert-Eaton叠加综合征
下载PDF
伴幻听儿童少年首发精神分裂症患者功能磁共振低频振幅研究 被引量:6
18
作者 李亚利 李坤 +6 位作者 王壁 梁颖慧 夏艳红 李玉玲 郭敬华 申华磊 郭素芹 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2019年第8期454-459,共6页
目的探讨伴与不伴幻听的儿童少年首发精神分裂症患者在静息状态下大脑功能磁共振低频振幅(amplitude of low-frequency fluctuation,ALFF)特点及其与精神症状之间的关系。方法收集10~16岁首发精神分裂症患者52例,根据阳性症状量表(posit... 目的探讨伴与不伴幻听的儿童少年首发精神分裂症患者在静息状态下大脑功能磁共振低频振幅(amplitude of low-frequency fluctuation,ALFF)特点及其与精神症状之间的关系。方法收集10~16岁首发精神分裂症患者52例,根据阳性症状量表(positive symptoms scale,SAPS)中听幻觉条目评分将患者分为幻听组26例(听幻觉≥3分)和非幻听组26例(听幻觉<3分),并纳入35名健康对照。对所有被试静息态功能磁共振扫描数据进行ALFF分析,用阳性与阴性症状量表(positive and negative syndrome scale,PANSS)评估患者症状。结果与对照组比较,幻听组ALFF振幅降低的脑区是左侧枕叶、左侧颞叶(P<0.05,AlphaSim校正),ALFF升高的脑区是左侧额叶(P<0.05,AlphaSim校正);非幻听组相比对照组ALFF增高的脑区是左侧额叶、右侧尾状核(P<0.05,AlphaSim校正);幻听组相较于非幻听组ALFF增高的脑区有右侧枕叶(P<0.05,AlphaSim校正)。幻听组右侧枕叶的ALFF值与PANSS阳性症状分(r=0.448,P=0.022)及总分(r=0.407,P=0.039)呈正相关;非幻听组右侧枕叶ALFF值与一般病理症状分呈正相关(r=0.630,P=0.001)。结论儿童少年首发精神分裂症患者在静息状态下左侧额叶和右侧尾状核功能增强,左侧枕叶和左侧颞叶功能降低;伴与不伴幻听的儿童少年精神分裂症患者在静息状态下枕叶功能存在差异,且与精神症状有相关性。 展开更多
关键词 精神分裂症 儿童少年 幻听 低频振幅 阳性与阴性症状量表
下载PDF
首发未治疗的精神分裂症患者低频振幅研究 被引量:3
19
作者 邓玲珑 张荣荣 +2 位作者 娄莹 刘献伟 胡君 《临床精神医学杂志》 2019年第4期243-246,共4页
目的:探讨首发未治疗的精神分裂症患者低频振幅(ALFF)改变及其与临床症状的关系。 方法:对69例首次发病未治疗的精神分裂症患者(患者组)及74名健康对照者(对照组)进行静息态功能磁共振(fMRI)扫描获取ALFF值;采用阳性和阴性症状量表(PAN... 目的:探讨首发未治疗的精神分裂症患者低频振幅(ALFF)改变及其与临床症状的关系。 方法:对69例首次发病未治疗的精神分裂症患者(患者组)及74名健康对照者(对照组)进行静息态功能磁共振(fMRI)扫描获取ALFF值;采用阳性和阴性症状量表(PANSS)评估患者的临床症状,分析ALFF与临床症状的关系。结果:与对照组相比,患者组右颞中回、右脑岛、右尾状核、右额上回、右顶下小叶、左顶上回ALFF值明显增高,右楔叶ALFF值明显降低(高斯随机场矫正,体素P<0.001;团块P<0.05),患者组右额上回ALFF值与PANSS阳性症状分(多重比较矫正,r=0.30,P<0.05)及总分(多重比较矫正,r=0.34,P<0.05)呈正相关。 结论:首发精神分裂症患者部分脑区脑功能活动异常,且异常活动脑区可能与临床症状相关。 展开更多
关键词 精神分裂症 低频振幅 临床症状
下载PDF
基于深度访谈扎根分析多发性硬化患者的症状波动及中医药疗效 被引量:5
20
作者 谢瑶 严冬 高颖 《世界中医药》 CAS 2019年第4期1041-1045,共5页
目的:从患者角度,深入了解多发性硬化症状波动对患者的影响,以及患者对中医药治疗多发性硬化的理解等方面。方法:本文采用半结构化深度访谈的定性研究方法,利用扎根理论对访谈资料进行总结分析。结果:研究结果发现多发性硬化症状波动可... 目的:从患者角度,深入了解多发性硬化症状波动对患者的影响,以及患者对中医药治疗多发性硬化的理解等方面。方法:本文采用半结构化深度访谈的定性研究方法,利用扎根理论对访谈资料进行总结分析。结果:研究结果发现多发性硬化症状波动可导致疾病症状、伴随症状、其他症状等多层面的不适,并且给患者带来无奈、急躁、恐惧、压抑、无助等心理变化,反之心理变化又加重患者症状的自我感受,自此恶性循环;患者所体会的中医药疗效主要在改善症状、稳定疾病活动、整体调节等方面。结论:针对多发性硬化,应当增加侧重以症状、心理、患者自我报告结局的评价维度,以全面且公正地评价多发性硬化疗效以及中医药对多发性硬化的疗效,制定以患者为中心的个体化诊治策略。 展开更多
关键词 多发性硬化 定性研究 深度访谈 中医药 症状波动
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部